EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Pilot Metabolomic Study for Diagnosing Aspergillus Infection in Immunocompromised Pediatric Cancer Patients

Taghreed Khaled Abdelmoneim iD, Asmaa Ramzy, Mostafa Ahmed Zaki iD, Ahmed Karam, Ahmed Hesham, Aya Osama, Nabila Sabar, Maha Mokhtar, Nada A Youssef iD, Eman A Ahmed iD, Lobna Shalaby, Asmaa Salama und 3 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26135926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Taghreed Khaled Abdelmoneim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt, Cairo 57357, Egypt. Hauptthemen laut MEDLINE: Immunocompromised Host, Aspergillosis, Metabolomics, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science, Technology & Innovation Funding Authority (STDF), Science, Technology & Innovation Funding Authority (STDF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal infection caused by invasive Aspergillus is a life-threatening complication in immunocompromised pediatric cancer patients. However, the early diagnosis of invasive infection remains a clinical challenge due to the lack of specific, non-invasive biomarkers. The current study investigates plasma metabolomic profiling integrated with an AI-derived fungal secondary metabolite database to identify potential biomarkers for rapid, non-invasive detection of Aspergillus infection. Plasma samples from thirteen pediatric oncology patients were analyzed using untargeted metabolomics based on UHPLC-MS/MS. Based on galactomannan assay results, three patients were classified as Aspergillus-Infected (AIC) and ten as non-infected controls (NPCs). An in-house custom database for secondary metabolites of fungi was incorporated to enhance metabolite annotation. Eight metabolites were found to be candidate biomarkers based on statistical significance, fold change, and biological relevance. In the AIC cohort, aflatoxin B1, aspergillimide, fumifungin, and uridine were found to be significantly elevated while citric acid presented a decrease. Multivariate analysis utilizing PCA and PLSDA showed distinct group separation. Moreover, sample size estimation indicates that a minimum of 25 participants would be needed in future studies for appropriate statistical power.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunocompromised HostAspergillosisMetabolomicsNeoplasmsHumansChildMaleFemalePilot ProjectsChild, PreschoolAspergillusAdolescentBiomarkersTandem Mass SpectrometryMetabolomeInfantGalactoseMannans

Stichwörter der Autor:innen

AspergillusLC-MS/MSfungal infectionmetabolomicspediatric cancer

Substanzen

BiomarkersgalactomannanGalactoseMannans

Autor:innen und Institutionen

  • Proteomics and Metabolomics Research Program, Basic Research Department, Children's Cancer Hospital Egypt, Cairo 57357, Egypt.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt.
  • Infectious Diseases Department, Children's Cancer Hospital Egypt, Cairo 57357, Egypt.
  • Pediatric Oncology Department, National Cancer Institute, Cairo University, Giza 12613, Egypt.
  • Pathology Department, Children's Cancer Hospital Egypt, Cairo 57357, Egypt.
  • Pathology Department, National Cancer Institute, Cairo University, Giza 12613, Egypt.

ORCID-Profile: Taghreed Khaled Abdelmoneim, Mostafa Ahmed Zaki, Nada A Youssef, Eman A Ahmed, Sameh Magdeldin

Förderung

  • Science, Technology & Innovation Funding Authority (STDF)
  • Science, Technology & Innovation Funding Authority (STDF)

Zitieren

APA

Abdelmoneim, T. K., Ramzy, A., Zaki, M. A., Karam, A., Hesham, A., Osama, A., Sabar, N., Mokhtar, M., Youssef, N. A., Ahmed, E. A., Shalaby, L., Salama, A., Kamel, A., Elenany, M., & Magdeldin, S. (2025). A Pilot Metabolomic Study for Diagnosing Aspergillus Infection in Immunocompromised Pediatric Cancer Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26135926

Vancouver

Abdelmoneim TK, Ramzy A, Zaki MA, Karam A, Hesham A, Osama A, et al. A Pilot Metabolomic Study for Diagnosing Aspergillus Infection in Immunocompromised Pediatric Cancer Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26135926

BibTeX
@article{Abdelmoneim2025,
  author = {Abdelmoneim, Taghreed Khaled and Ramzy, Asmaa and Zaki, Mostafa Ahmed and Karam, Ahmed and Hesham, Ahmed and Osama, Aya and Sabar, Nabila and Mokhtar, Maha and Youssef, Nada A and Ahmed, Eman A and Shalaby, Lobna and Salama, Asmaa and Kamel, Ahmed and Elenany, Mervat and Magdeldin, Sameh},
  title = {A Pilot Metabolomic Study for Diagnosing Aspergillus Infection in Immunocompromised Pediatric Cancer Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26135926}
}
Kostenlos starten →